

HY-15728 · 5 mg
MedChemExpress · Cat: HY-15728
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/Radotinib.html
Description
Radotinib IY-5511 is an orally active and BBB-permeable selective tyrosine kinase Bcr-Abl1 inhibitor with an IC50 of 34 nM. Radotinib has anti-prion and anti-tumor activities. Radotinib can inhibit the proliferation, induce cell cycle arrest and apoptosis of tumor cells . Radotinib can be used in the research of cancer such as chronic myeloid leukemia and multiple myeloma, as well as neurodegenerative diseases such as prion diseases.







